CLDWW CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM)

Watchlist

0.010
0.0000.00%

15min DelayTrading Dec 30 16:00 ET

0Market Cap0.00P/E (TTM)

CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM) Key Stats

According to the latest financial report of CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM), the latest earnings per share (TTM) for the company is --. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

FCF

Interested in knowing about CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM)'s free cash flow? The latest report shows it as -4.95M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM) shows that the company's current ratio is 0.19, indicating healthy liquidity.

Currency: USD

Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM), the quick ratio is 0.16, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

ROE

Want to learn more about the financial health of CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM)? The latest ROE figure is --, indicating that the company has stable profitability.

Currency: USD

Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM), the total asset return on investment (ROA) is -77.23%.

Currency: USD

Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM)'s latest financial report to see how their gross margin is doing - currently at 87.65%.

Currency: USD

Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM), the net profit margin is -861.48%, which is a good sign for its profitability.

Currency: USD

Quarterly

Trending US Stocks